Clinical practice of defibrillator implantation after myocardial infarction: Impact of implant time: Results from the PreSCD II Registry

Europace

Volumn 13, Issue 4, 2011, Pages 499-508

  Völler, Heinz ^a   Kamke, Wolfram ^b   Klein, Helmut U ^c   Block, Michael ^d   Reibis, Rona ^a   Treusch, Sven ^e   Contzen, Klaus ^e   Wegscheider, Karl ^f  

^a Rehabilitation Center for Cardiovascular Diseases   (Germany)

^b Spreewaldklinik ^*  (Germany)

^c UNIVERSITY OF ROCHESTER   (United States)

^d Klinik Augustinum   (Germany)

^e Boston Scientific   (Belgium)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ICD therapy; Myocardial infarction; Primary prevention; Sudden cardiac death; Time of implantation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; GERMANY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REHABILITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUDDEN DEATH; SURVIVAL;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953769259     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq426     Document Type: Article

References (35)

1. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Juhani Airaksinen KE et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003;42:652-8. (Pubitemid 37000180)
2. Yap YG, Duong T, Bland M, Torp-Pedersen C, Køber L, Connolly SJ et al. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J 2005;26:1385-93. (Pubitemid 41373515)
3. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-8. (Pubitemid 41007844)
4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
5. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54. (Pubitemid 30648765)
6. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
8. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8. (Pubitemid 39603155)
9. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
10. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008;359:2245-53.
11. Moss AJ. Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. Circulation 2000;101:1638-40. (Pubitemid 30196620)
12. Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004;109:1082-4. (Pubitemid 38332609)
13. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61. (Pubitemid 35192824)
14. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235.
15. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003;24:13-5. (Pubitemid 36109541)
16. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-346.
17. Jünger C, Rauch B, Schneider S, Liebhart N, Rauch G, Senges J et al. Effect of early short-term cardiac rehabilitation after acute ST-elevation and non-ST-elevation myocardial infarction on 1-year mortality. Curr Med Res Opin 2010;26:803-11.
18. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009;361:1427-36.
19. Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC Jr. Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2009;119:503-14.
20. Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry. Heart 2009;95:216-20.
21. Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation 2009;120:194-200.
22. Ruskin JN, Camm AJ, Zipes DP, Hallstrom AP, McGrory-Usset ME. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients. J Cardiovasc Electrophysiol 2002;13:38-43. (Pubitemid 34113618)
23. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA et al. Sex and racial differences in the use of implantable cardioverter- defibrillators among patients hospitalized with heart failure. JAMA 2007;298:1525-32. (Pubitemid 47529386)
24. Moss AJ, Vyas A, Greenberg H, Case RB, Zareba W, Hall WJ et al. Temporal aspects of improved survival with the implanted defibrillator (MADIT-II). Am J Cardiol 2004;94:312-5. (Pubitemid 38962695)
25. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-96.
26. Goldenberg I, Moss AJ, McNitt S, ZarebaW, Andrews ML, Hall WJ et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006;98:485-90. (Pubitemid 44162874)
27. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 2008;52:1179-99.
28. de Sousa MR, Morillo CA, Rabelo FT, Nogueira Filho AM, Ribeiro AL. Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis. Eur J Heart Fail 2008;10:1007-14.
29. Olshansky B, Poole JE, Johnson G, Anderson J, Hellkamp AS, Packer D et al. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. J Am Coll Cardiol 2008;51:1277-82. (Pubitemid 351410535)
30. Dissmann R, Kamke W, Reibis R, Herbstleb J, Wegscheider K, Voller H. Prognostic impact of left bundle-branch block in the early stable phase after acute myocardial infarction. Int J Cardiol 2008;130:438-43.
31. Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB et al. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme. Eur J Heart Fail 2007;9:510-7. (Pubitemid 46561486)
32. Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA 2008;300:2022-9.
33. Chan PS, Hayward RA. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study. J Am Coll Cardiol 2005;45:1474-81. (Pubitemid 40615622)
34. Chan PS, Chow T, Kereiakes D, Schloss EJ,Waller T, Eagle K et al. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction. Arch Intern Med 2006;166:2228-33. (Pubitemid 44753827)
35. Law MR, Watt HC, Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med 2002;162:2405-10. (Pubitemid 35340454)